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Summary
Polymorphisms in genes involved in spermatogenesis are considered potential risk
factors for male infertility. Recently a polymorphism in the deleted in azoospermia-like
(DAZL) gene (T54A) was reported as susceptibility factor to oligo/azoospermia in the
Chinese population. DAZL is an autosomal homologue of the Y chromosomal DAZ
(deleted in azoospermia) gene cluster and both are considered master regulators of
spermatogenesis. The aim of the present study was to screen (i) for mutations of the
entire coding sequence of the DAZL gene in patients lacking of the DAZ gene cluster, in
order to evaluate if DAZL polymorphisms may influence the AZFc deletion phenotype;
(ii) for the two previously described (and eventually newly identified) single nucleotide
polymorphisms (SNPs) in a large group of infertile and normospermic men of Italian
origin. We failed to detect new mutations. We confirmed previous results showing no
evidence for a functional role of the T12A mutation. Surprisingly, the T54A
polymorphism, which was present in 7.4% of the Chinese patients was absent in our
Caucasian population. This remarkable difference represent an example of how ethnic
background is important also for polymorphisms involved in spermatogenesis and
contributes to better select clinically relevant tests, specifically based on the ethnic origin
of the infertile patients.
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Introduction
The list of potential and ascertained factors influencing
male fertility is steadily increasing mainly because of recent
progresses achieved in molecular genetics. Among them Y
chromosome microdeletions represent one of the most
frequent causes of oligoastenoteratozoospermia (5–7%) and
azoospermia (12–15%) (Krausz et al., 2003). The Y micro-
deletions associated with infertility occur in specific regions
of the long arm of the Y, called azoospermia factor (AZF)
regions (Vogt et al., 1996; Repping et al., 2002). A strict
genotype-phenotype correlation is observed only for the
deletion of the entire AZFa and AZFb regions which are
associated with the complete absence of germ cells in the
testis and spermatogenic arrest (in general at the stage of
spermatocytes), respectively (Vogt et al., 1996; Krausz et al.,
2003). On the contrary, the deletion of the most distal
AZFc region is associated with a heterogeneous phenotype
in different individuals, ranging from the absence of germ
cells in the testis to a severe reduction of sperm number/
motility and morphology in the ejaculate (oligoasthenote-
ratozoospermia) (Krausz et al., 2001a). This phenomenon
suggests that although spermatogenesis may start without
AZFc genes, their absence is crucial for a quantitatively and
qualitatively normal spermatogenesis. This region contains a
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total of eight gene families (BPY2, CDY1, DAZ, TTY3.1,
TTY4.1, TTY17.1; CSPG4LY and GOLGA2LY) (Skalet-
sky et al., 2003). The first multicopy gene identified in the
region was the deleted in azoospermia (DAZ) which
belongs to a gene family that consists of the two autosomal
single copy genes: BOULE and DAZ-like (DAZL) and the
Y specific DAZ (Reijo et al., 1995; Cooke et al., 1996;
Yen et al., 1996; Yen, 2004). All members of the family are
expressed exclusively in the germ cells and encodes proteins
containing a highly conserved RNA-type RNA-recogni-
tion motif (RRM) and a unique DAZ repeat of 24 amino
acid residues (Habermann et al., 1998; Reijo et al., 2000;
Shan et al., 1996; Xu et al., 2001; Yen, 2004). Besides struc-
tural homologies, the abilities of the human BOULE gene
to rescue the spermatogenic defect in Drosophila boule
mutants (Xu et al., 2003), and human DAZ and DAZL
transgenes to partially rescue the mouse Dazl null pheno-
type (Slee et al., 1999; Vogel et al., 2002) indicate that the
functions of these genes are also highly conserved between
species. Taken together these data, it is plausible that the
absence of the DAZ gene, because of AZFc microdeletion,
can be partially compensated by a fully efficient DAZL
gene or in alternative mutations/polymorphic variants in
the DAZL gene may lead to a more severe phenotype in
AZFc deleted patients. DAZ was copied to the Y chromo-
some relatively recently, in the old world primate lineage
and is 90% identical to its autosomal ancestor DAZL
(Saxena et al., 1996). No mutations for the DAZL and
BOULE genes have been reported so far, except two single
nucleotide polymorphisms (SNPs) in the DAZL gene
sequence in exon 2 and exon 3 (Teng et al., 2002). In
the Chinese population a significant association between
the presence of the SNP (A to G transition) in exon 3 at
nucleotide position 386 and oligozoospermia (p ¼ 0.0003)
has been found whereas the SNP (A to G transition) at
nucleotide position 260 was similarly distributed among
infertile (3.52%) and control men (2.59%). The mutation in
exon 3 is situated within the highly conserved RNA-
recognition motif domain of the DAZL protein and leads
to Thr54 fi Ala change (T54A). Thr54 is conserved for
both DAZL and DAZ and it is likely that this mutation
may lead to functional consequences such as reduced RNA
binding capacity. This would explain the observed similar-
ity in the phenotypic expression of the T54A mutation and
the DAZ gene (AZFc) deletion.
The aim of the present study was to evaluate, through
mutational analysis of the entire coding sequence of the
DAZL gene, the influence of the two known and
eventually of newly identified mutations on the spermato-
genic potential of AZFc deleted men. In addition, in order
to establish if any of the previously described SNPs may
represent a risk factor for spermatogenic failure and thus
could be proposed as a new diagnostic test, we analysed a
large group of infertile and control normospermic men of
Italian origin.
Materials and methods
Subjects
The study population consisted of 242 patients of Italian
origin seeking complete andrological work-up for couple
infertility at the Andrology Unit of the University Hospital
Careggi (Florence). All patients underwent comprehensive
andrological examination including semen analysis, karyo-
type and Y chromosome microdeletion screening. At the
end of the clinical work-up the patients have been divided
into three categories: (i) idiopathic (n ¼ 92): patients with
no abnormal andrological findings in their medical history
and at the medical examination, normal hormone levels and
normal genetic tests; (ii) co-factor+ (n ¼ 61) presence of
co-factors with potential negative effect on the spermato-
genesis i.e. unilateral varicocele, previous infections of the
urogenital tract, heavy smoking, monolateral cryptorchi-
dism; (iii) non-idiopathic (n ¼ 89): presence of abnormal
andrological findings with clearly established negative effect
on spermatogenesis i.e. karyotype abnormalities, obstructive
azoospermia, bilateral cryptorchidism, bilateral second to
third grade varicocele, iatrogenic, bilateral orchitis, hypogo-
nadotrophic hypogonadism.
A selected group of 12 patients bearing complete AZFc
deletions has been screened separately.
Patients in each category (idiopathic, co-factor+ and
non-idiopathic) have been further divided into subgroups
on the basis of their sperm count: azoospermic (the
complete absence of spermatozoa), cryptozoospermia
(<1 million spermatozoa/mL); severe oligozoospermia (1–5
millions spermatozoa/mL), moderate oligozoospermia
(5–20 milions spermatozoa/mL), asthenoteratozoospermia
(total progressive motility <50% with total normal
morphology <30%) pure teratozoospermia.
A total of 229 Italian men with normal sperm parameters
have been recruited mainly from the Florence area. Ninety
men fathered at least one child or had normal fertilization
after IVF for pure tubal factor infertility.
All subjects gave an informed consent for molecular
analysis of their blood samples.
Semen analysis
Semen analysis has been performed according to the
World Health Organization (WHO) (1992) guidelines at the
Andrology Laboratory of the University Hospital of Careggi
(Florence).
Molecular analysis
DNA source. The DNA has been extracted from peripheral
lymphocytes in the infertile group and in 129 controls
whereas DNA was isolated from frozen semen in 100
controls.
For detection of the polymorphisms at nucleotide
position 260 and 386 we performed polymerase chain
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reactions (PCRs) in 25 lL containing 200 ng of genomic
DNA, 10 mM Tris-HCl (pH 8,3), 50 mM KCl, 0.1% Triton
X-100, 200 lM deoxynucleotide triphosphates, 100 pmol of
each primer, and 1 U Taq DNA polymerase (Promega
Corp., Madison, WI, USA). DNA samples were amplified at
following conditions: 5 min 94 C; 30X 30 sec 94 C,
30 sec 58 C, 30 sec 72 C; 5 min 72 C. The primer
sequences used for detection of SNP260 in exon 2 and
SNP386 in exon 3 are reported in the paper by Teng et al.
(2002).
The mutation in exon 2 leads to a Thr12-Ala change
(T12A) of the DAZLA protein. The T12A variant creates a
DdeI restriction site (CTNAG). On digestion, gel electro-
phoresis, in agarose gel, showed 67- and 197-bp fragments
for the variant, instead of the 264-bp fragment of wild-type
allele. Sequence analysis was performed with automatic
sequencer (ABI 310; PE Applied Biosystems, Foster City,
CA, USA) for all patients presenting the A variant.
The mutation in exon 3 leads to a Thr54-Ala change
(T54A) of the DAZLA protein. Sequence analysis was
performed with automatic sequencer (ABI 310; PE Applied
Biosystems) in 242 infertile and 100 normal controls.
Statistical analysis
Statistical analysis has been performed using the statistical
package SPSS for Windows (version 11, SPSS Inc. Chicago,
IL, USA). All variables were checked for normal distribution
by Kolmogorov–Smirnov one sample test.
For comparisons of mean values between groups of
different genotypes Student t-test for independent samples,
when normal distribution was observed, has been applied.
Logarithmic transformation of data has been performed in
order to normalize the distribution when the presence of
log normal distribution was checked. Finally, in case of
non-normalized distribution, the nonparametric test
Mann–Whitney U-test was applied to achieve the same
objective.
Allele frequencies were calculated by the allele counting
method and the Hardy–Weinberg equilibrium was con-
firmed v2 ¼ 0.6291 and 0.5706 for patients and controls,
respectively). Differences in genotype and allele frequencies
between patients and controls were compared by chi-square
test and Fisher’s exact test was used when appropriate.
A p-value <0.05 was considered statistically significant in
each situation. The null hypothesis of means (or median)
equality has been refused.
Results
Mutation screening by direct sequencing of the DAZL gene in
patients affected by AZFc deletions
In order to evaluate an eventual modulating effect of
DAZL variants or mutations on the AZFc phenotype, a
mutational analysis of the entire coding sequence of the
DAZL gene has been performed in 12 patients affected by
complete AZFc deletions. No new mutations or SNPs have
been detected. In one patient with cryptozoospermia the
previously described SNP260 (A to G transition) was found
in heterozygosis. The genotype and semen parameters of
these patients are reported in Table 1.
Search for polymorphisms (T12A and T54A) in the Italian
population
Frequency and distribution of the T12A (SNP260) allele of the
DAZL gene in controls vs. patients. The most frequently
observed allele in both controls and patients was the
common T allele (Teng et al., 2002). The variant T12A
was found both in homozygosis and heterozygosis.
The frequency of the SNP260 genotypes (AA; AG; GG)
in the control and the entire patient population (including
idiopathic, cofactor+ and non-idiopathic patients) was
comparable. A further subdivison of the patient population
on the basis of the aetiology and semen parameters was
unable to identify significant differences for any of the
subgroups vs. controls (Table 2).
Effect of SNP260 on sperm parameters. In order to assess if
the presence of the G substitution (genotypes AG and GG)
is able to influence spermatogenesis or sperm function, we
compared the mean values of the three principal sperm
parameters (concentration, morphology and motility) among
men with and without the G substitution. The mean values
of the three parameters were not significantly different
between the two groups, in both normospermic and infertile
men (Fig. 1a,b).
Table 1. DAZL genotypes in 12 patients bearing AZFc deletions.
Sperm analysis has been performed according to WHO guidelines
(WHO, 1992). Total number (millions spermatozoa/mL); motility
(% of type a + b); morphology (% of normal forms)
Code
Y chromosome
deletion
DAZLA
SNP 260
Semen parameters
Total
number
Motility
(%)
Morphology
(%)
A1 AZFc AA 0
A21 AZFc AA 0
A50 AZFc AA 0
A57 AZFc AA 0.01
A81 AZFc AG 0.01
A116 AZFc AA 0.01
A129 AZFc AA 1.20 4 0
A189 AZFc AA 0
A208 AZFc AA 0.01
A282 AZFc AA 1.4 5 0
A302 AZFc AA 1.8 6 4
A336 AZFc AA 0
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Frequency and distribution of the T54A (SNP386) allele of the
DAZL gene in controls vs. patients. Direct sequencing of
exon 3 (Fig. 2) has failed to detect the A to G transition in
nucleotide position 386 both in the control and patient
group. This finding indicates a sharp contrast with the
relatively high frequency of the T54A allele in the Chinese
infertile population (7.39%).
Discussion
Male infertility is a multifactorial pathological condition
mainly (approximately 70%) because of factors acting directly
in the testes (Forti & Krausz, 1998). Although some of them
induce a homogeneous phenotype (complete AZFa and
AZFb deletions of the Y chromosome), the majority of
pathogenic factors (Klinefelter sdr, cryptorchidism, chemio/
radiotherapy, varicocele, environmental toxic factors, AZFc
deletions) cause different degree of spermatogenic failure in
different individuals. This interindividual variability is likely
to be related to the genetically determined spermatogenic
potential of each individual.
Polymorphisms or genetic variants in genes involved in
spermatogenesis are considered potential risk factors which
may contribute to the severity of spermatogenic failure.
Several polymorphic variants have been described in
association with oligo/azoospermia (Fritsche et al., 1998;
Dowsing et al., 1999; Ruiz-Pesini et al., 2000; van der Ven
et al., 2000; Holyoake et al., 2001; Krausz et al., 2001a,b; St
John et al., 2001; Kukuvitis et al., 2002; Rajpert-De Meyts
et al., 2002; Tsujimura et al., 2002; Asatiani et al., 2003;
Tanaka et al., 2003; Yong et al., 2003), and among them a
DAZL polymorphism (T54A) has been reported as a
susceptibility factor to oligo/azoospermia in the Chinese
population. This mutation represents the first example of a
SNP in an autosomal gene influencing human spermato-
genesis. Independently from this finding, the presence of the
T54A allele does not worsen the phenotype of AZFc deleted
men (Teng et al., 2002). However, the lack of effect in this
selected group of patients can be related to the influence of
other AZFc homologous genes.
Data on DAZL mutations are limited in the literature as
only one population has been screened so far (Teng et al.,
2002). Therefore, in order to asses whether the two known
mutations/variants may influence the spermatogenic poten-
tial of AZFc deleted men, and to explore for the presence
of yet unidentified mutations, we performed a mutational
analysis of the entire coding region of the gene in 12
patients bearing the AZFc deletion. The screening did not
lead to the detection of new mutations, and the only
variant found was the G to A transition in exon 2
(SNP260) in one cryptozoospermic patient. Only three of
12 patients had a less severe grade of spermatogenic failure
with respect to the heterozygous patient, which suggests
little or no functional effect of this variant on spermato-
genesis.
The screening for the two previously described SNPs
in a large group of patients and normospermic men gave a
surprising outcome. The previously described susceptibility
polymorphism, T54A reported to be present at a relatively
high frequency in the infertile group (7.39%) and
significantly different from that observed in the control
group (0.86%), was completely absent in a Caucasian
population such as the Italian population. On the contrary,
in accordance to the Chinese study, the frequency of
SNP260 was not different between infertile and control
patients. Given that the group of infertile men was
constituted by a heterogeneous population both for
aetiological factors and sperm counts, we further subdivi-
ded the study population and compared them with the
control population. Nevertheless, no specific at risk
subgroup has been identified. This data, together with
the absence of significant differences concerning the mean
Table 2. DAZL genotypes in the whole study group. Values in parenthesis are expressed as percentages
Group
DAZL genotypes
Total (n) p-value vs. controlsAA AG GG
Classification criteria Controls 176 (76.8) 48 (20.9) 5 (2.2) 229
All patients 173 (71.5) 65 (26.8) 4 (1.65) 242 0.332
Aetiology Idiopathic 64 (69.6) 26 (28.3) 2 (2.2) 92 0.387
Cofactor+ 44 (72.1) 17 (27.9) 0 (0) 61 0.332
Idiopathic and cofactor+ 108 (70.6) 43 (28.1) 2 (1.3) 153 0.260
Non-idiopathic 65 (73.0) 22 (24.7) 2 (2.2) 89 0.729
Sperm count* (millions/mL) 0–1 40 (76.9) 11 (21.1) 1 (1.9) 52 0.993
<5 45 (69.2) 19 (29.2) 1 (1.5) 65 0.368
>5 23 (63.9) 13 (36.1) 0 (0) 36 0.114
*Non-idiopathic infertile patients have been excluded.
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values of the three sperm parameters (sperm count,
motility and morphology) in both the infertile and in
the control groups and the presence of five homozygous
mutants with normozoospermia, suggests that this poly-
morphism has no evident functional role in spermato-
genesis.
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Figure 1. Comparison of sperm parameters among men bearing homozygous wild type alleles vs. subjects with the mutated allele (a) in normospermic controls
(b) in patients with idiopathic and cofactor+ infertility. No significant differences has been observed for any of the three parameters evaluated, both in controls
and patients in relation to the SNP genotypes. Sperm analysis has been performed according to WHO guidelines (WHO, 1992). Total number (millions
spermatozoa/mL); motility (% of type a + b); morphology (% of normal forms).
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Our study, based on a large group of infertile and
normospermic men clearly indicates that the screening for
T54A (and T12A) does not provide a new diagnostic tool in
a Caucasian population. A similar conclusion has been made
by another preliminary study dealing with a low number of
patients (n ¼ 95) and controls (n ¼ 65) from Caucasian
origin and using a different method for the detection of this
polymorphism (Bartoloni et al., 2004). However, this
polymorphism could be taken into consideration as a
potential new marker for population genetic studies.
Discrepancies between results of association studies is a
rather frequent phenomenon and may be related to many
different factors (Ioannidis et al., 2001). An important feature
of this study is that the discrepancy between our analysis and
the Chinese study is not related to sampling biases (small
sample size, inadequate control group or population sub-
structuring), but it is related to the complete absence of the
at risk SNP in 300 subjects, indicating that in Italy this
polymorphism is probably absent or extremely rare. This
remarkable difference is paradigmatic as it shows how ethnic
background is important for polymorphisms involved in
spermatogenesis, thereby underscoring that different genetic
risk factors may be present in different populations. A
similar phenomenon is observed for cystic fibrosis trans-
membrane conductance regulator (CFTR) gene mutations
causing azoospermia because of congenital bilateral absence
of vas deferens (CBAVD). The frequency of a particular
CFTR mutation is also influenced by the ethnic composi-
tion of the population analysed (Patrizio & Leonard, 2000).
Our study therefore contributes to a better definition of
clinically relevant tests, specifically based on the ethnic origin
of the infertile patients.
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